Cargando…
Con: Can biomarkers be gold standards in Alzheimer's disease?
As Alzheimer's disease remains a clinical diagnosis, and as clinical diagnosis can be difficult, it makes sense to look for so-called biomarkers. A biomarker predicts who is likely to have the illness and who is not. Some biomarkers might even correlate with a clinically meaningful response to...
Autor principal: | Rockwood, Kenneth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919696/ https://www.ncbi.nlm.nih.gov/pubmed/20587007 http://dx.doi.org/10.1186/alzrt40 |
Ejemplares similares
-
Pro: Can biomarkers be gold standards in Alzheimer's disease?
por: Sperling, Reisa, et al.
Publicado: (2010) -
Con: Can neuropathology really confirm the exact diagnosis?
por: Jellinger, Kurt A
Publicado: (2010) -
Can Standards and Regulations Keep Up With Health Technology?
por: Vincent, Christopher James, et al.
Publicado: (2015) -
Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?
por: Rockwood, Kenneth
Publicado: (2011) -
Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
por: Zhou, Yixiu, et al.
Publicado: (2018)